Impact of Arteriovenous Fistula Closure on Cardiac and Renal Function in Renal Transplantation Patients

Abstract

<title>Abstract</title> <bold>Background: </bold>Due to the rapid expansion of numerous national and international transplantation programs, hemodialysis (HD) and peritoneal dialysis (PD) have become vital interim treatments for patients awaiting kidney transplantation. <bold>Aim and objectives: </bold>Assessment of the effects of AV fistula ligation on cardiac and renal function in post-kidney transplant patients. <bold>Patients and methods:</bold> A total of 98 kidney transplant recipients were divided into two groups: patients with closed arteriovenous fistula (AVF) (46) and patients with patent AVF (52). The study was done in outpatient nephrology clinics at Minia University and Minia Governorate Insurance Hospital. <bold>Results</bold>: There was significant variation in terms of major and minor right-side diameter, IVC, PASP, MPAP, left ventricular hypertrophy, and left ventricular DD. In addition, there was a significant difference between the two groups regarding serum creatinine, urea, and eGFR. <bold>Conclusion:</bold> AVF closure in renal-transplant patients can protect against severe cardiac changes and deterioration of eGFR.